The nature and regulation of the receptors for insulin-like growth factors - PubMed (original) (raw)
Review
The nature and regulation of the receptors for insulin-like growth factors
M M Rechler et al. Annu Rev Physiol. 1985.
Abstract
Two subtypes of IGF receptors have been identified. Type I IGF receptors have a Mr greater than 300,000 and are composed of disulfide-linked 130,000-dalton (alpha) and approximately 90,000-dalton (beta) subunits. The alpha subunit binds hormone; the beta subunit appears to have intrinsic tyrosine kinase activity and to be autophosphorylated. Type I receptors preferentially bind IGF-I but also bind IGF-II and, more weakly, insulin. Type II IGF receptors consist of a 250,000-dalton protein that contains internal disulfide bonds but is not linked to other membrane components. Type II receptors bind IGF-II with higher affinity than IGF-I. They do not interact with even very high concentrations of insulin. Type I IGF receptors and insulin receptors are homologous structures. They have similar subunit structure. Both receptors bind IGFs and insulin. They have similar (but not identical) antigenic determinants. Both receptors are downregulated by IGFs and insulin. Both receptors are affected in certain patients with genetically determined insulin resistance. Type II IGF receptors do not appear to be homologous to type I receptors. They differ in structure, peptide binding specificity, and antigenic determinants. Type II receptors do not appear to be downregulated. Although type II receptors appear to be phosphorylated in intact cells, they do not possess intrinsic tyrosine protein-kinase activity. Insulin acutely upregulates type II IGF receptors in intact rat adipose cells by effecting a redistribution of receptors cycling between a large intracellular pool and the plasma membrane. Insulin and the IGFs elicit the same biological responses, either by cross-reacting with one of the receptors for the heterologous ligand or by concurrent activation of convergent effector pathways by binding to the homologous receptor. Which mechanism is utilized appears to depend more on the tissue than on the biological response. Insulin desensitizes rat hepatoma cells to the actions of insulin and IGFs, mediated by both insulin and IGF receptors, by mechanisms distal to hormone binding and possibly common to IGF and insulin effector pathways.
Similar articles
- Somatomedin/insulin-like growth factor tissue receptors.
Nissley SP, Rechler MM. Nissley SP, et al. Clin Endocrinol Metab. 1984 Mar;13(1):43-67. doi: 10.1016/s0300-595x(84)80008-0. Clin Endocrinol Metab. 1984. PMID: 6202447 Review. - Interaction of insulin-like growth factors with a nonfusing mouse muscle cell line: binding, action, and receptor down-regulation.
de Vroede MA, Romanus JA, Standaert ML, Pollet RJ, Nissley SP, Rechler MM. de Vroede MA, et al. Endocrinology. 1984 May;114(5):1917-29. doi: 10.1210/endo-114-5-1917. Endocrinology. 1984. PMID: 6325137 - Receptors for insulin-like growth factors in the central nervous system: structure and function.
Gammeltoft S, Ballotti R, Nielsen FC, Kowalski A, Van Obberghen E. Gammeltoft S, et al. Horm Metab Res. 1988 Jul;20(7):436-42. doi: 10.1055/s-2007-1010854. Horm Metab Res. 1988. PMID: 2971601 Review. - Interrelationships among receptor structures for insulin and peptide growth factors.
Czech MP, Oppenheimer CL, Massagué J. Czech MP, et al. Fed Proc. 1983 Jun;42(9):2598-601. Fed Proc. 1983. PMID: 6303863 - Demonstration of type I and type II somatomedin receptors on bovine growth plate chondrocytes.
Trippel SB, Chernausek SD, Van Wyk JJ, Moses AC, Mankin HJ. Trippel SB, et al. J Orthop Res. 1988;6(6):817-26. doi: 10.1002/jor.1100060605. J Orthop Res. 1988. PMID: 2971791
Cited by
- NGF, EPO, and IGF-1 in the Male Reproductive System.
Metallinou C, Staneloudi C, Nikolettos K, Asimakopoulos B. Metallinou C, et al. J Clin Med. 2024 May 15;13(10):2918. doi: 10.3390/jcm13102918. J Clin Med. 2024. PMID: 38792459 Free PMC article. Review. - Biofunctionalization and Applications of Polymeric Nanofibers in Tissue Engineering and Regenerative Medicine.
Phutane P, Telange D, Agrawal S, Gunde M, Kotkar K, Pethe A. Phutane P, et al. Polymers (Basel). 2023 Feb 27;15(5):1202. doi: 10.3390/polym15051202. Polymers (Basel). 2023. PMID: 36904443 Free PMC article. Review. - Insulin-like growth factor-1 receptor controls the function of CNS-resident macrophages and their contribution to neuroinflammation.
Ivan DC, Berve KC, Walthert S, Monaco G, Borst K, Bouillet E, Ferreira F, Lee H, Steudler J, Buch T, Prinz M, Engelhardt B, Locatelli G. Ivan DC, et al. Acta Neuropathol Commun. 2023 Mar 8;11(1):35. doi: 10.1186/s40478-023-01535-8. Acta Neuropathol Commun. 2023. PMID: 36890580 Free PMC article. - The factors affecting neurogenesis after stroke and the role of acupuncture.
Mu JD, Ma LX, Zhang Z, Qian X, Zhang QY, Ma LH, Sun TY. Mu JD, et al. Front Neurol. 2023 Jan 20;14:1082625. doi: 10.3389/fneur.2023.1082625. eCollection 2023. Front Neurol. 2023. PMID: 36741282 Free PMC article. Review. - Insulin facilitates corneal wound healing in the diabetic environment through the RTK-PI3K/Akt/mTOR axis in vitro.
Peterson C, Chandler HL. Peterson C, et al. Mol Cell Endocrinol. 2022 May 15;548:111611. doi: 10.1016/j.mce.2022.111611. Epub 2022 Feb 26. Mol Cell Endocrinol. 2022. PMID: 35231580 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical